Ruiz-Moreno M., Rua MJ, Molina J., et al. Prospective randomized trial of interferon alpha in children with chronic hepatitis B. Hepatology. 1991;13:1035-1039.
2.
Ruiz-Moreno M., Jimenez J., Porres JC, et al. A controlled trial of recombinant interferon alpha in Caucasian children with chronic hepatitis B. Digestion. 1990;45:26-33.
3.
Utili R., Sagnelli E., Galanti B., et al. Prolonged treatment of children with chronic hepatitis B with a recombinant alpha 2a interferon: a controlled randomized study. Am J Gastroenterol.1991;86:327-330.
4.
La Banda F., Ruiz-Moreno M., Carreno V., et al. Recombinant alpha 2 interferon treatment in children with chronic hepatitis B. [letter]Lancet. 1988;1:250.
5.
Lai CL, Lin HJ, Lau JN, et al. Effect of recombinant alpha 2 interferon with or without prednisone in Chinese HBsAg carrier children. QJ Med.1991;78:155-163.
6.
Kay M., Wyllie R., Deimler C., et al. Alpha interferon therapy in children with chronic active hepatitis B and delta virus infection. J Pediatr.1993 ;123:1001-1004.
7.
Immunization Practices Advisory Committee (ACIP), Centers for Disease Control.Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. MMWR.1991;40(RR-13):1-25.
8.
Committee on Infectious Diseases, American Academy of Pediatrics.Universal hepatitis B immunization . Pediatrics.1992;89:785-800.
9.
Jacobs S. Hepatitis BImmunization: Pediatrician's perspective. Pediatrics. 1994;93:151. Letter.
10.
Schiff ERClinical aspects of hepatitis C virus infection and recommendations for therapy. In: National Hepatitis Detection, Treatment, and Prevention Program. Hepatitis C in Perspective. Physicians World Communications Group.1993;13-18.
11.
Davis GL, Balart LA, Schiff ER, et al. Treatment of chronic hepatitis C with recombinant interferon alpha. N Engl J Med.1989;321:1501-1506.
12.
Yuki N., Hayashi N., Takehara T., et al. Serum hepatitis C virus RNA levels and liver injury in volunteer blood donors. Am J Gastroenterol.1994;89:1462-1466.
13.
Gitnick G.Detection of hepatitis C virus: evolving scientific and clinical status . In: National Hepatitis Detection, Treatment and Prevention Program. Hepatitis C in Perspective. Physicians World Communications Group. 1993:7-12.
14.
Wejstal R., Widell A., Mansson A.Mother-to-infant transmission of hepatitis C virus. Ann Intern Med.1992;117:887-890.
15.
Reinus JF, Leiken E., Alter J., et al. Failure to detect vertical transmission of hepatitis C virus . Ann Intern Med.1992;117:881-886.
16.
Bortolotti F., Jara P., Diaz C., et al. Posttransfusion and community acquired hepatitis C in childhood. J Pediatr Gastroenterol Nutr. 1994;18:279-283.
17.
A-kader HH, Balistreri WFHepatitis C virus: implications to pediatric practice. Pediatr Infect Dis J.1993;12:853-867.
18.
Ohto H., Terazawa S., Sasaki N., et al. Transmission of hepatitis C virus from mothers to infants. N Engl J Med.1994;330:744-750.
19.
Thaler MM, Park CK, Landers DV, et al. Vertical transmission of hepatitis C virus. Lancet. 1991;338:17-18.
20.
Giovannini M., Tagger A., Ribero MLMaternal infant transmission of hepatitis C virus and HIV infections: a possible interaction. Lancet . 1990;335:1166. Letter.
21.
Kelen GD, Green GB, Purcell RHHepatitis B and hepatitis C in emergency department patients. N Engl J Med.1992;326:1394-1404.
22.
Ruiz-Moreno M., Rua MJ, Castillo I., et al. Treatment of children with chronic hepatitis C with recombinant interferon-alpha: a pilot study. Hepatology. 1992;16:882-885.
23.
Lomas R.Hepatitis C: you cannot blame it on your mother. Am J Gastroenterol.1993;88:1972-1973.
24.
Peters M.Mechanisms of action of interferons. Semin Liver Dis . 1989 ;9:235-239.
25.
Baron S., Tyring SK, Fleischmann WRJr, et al. The interferons: mechanisms of action and clinical applications . JAMA.1991;266:1375-1383.
26.
Hoofnagle JH , Peters M., Mullen KD, et al. Randomized controlled trial of recombinant human alpha interferon in patients with chronic hepatitis B. Gastroenterology. 1988;95:1318-1325.
27.
Brook MG, Karayiannis P., Thomas HCPatients with chronic hepatitis B virus infection will respond to alpha interferon therapy? A statistical analysis of predictive factors. Hepatology . 1989; 10:761-763.
28.
Moyes CD, Milne A., Waldon F., et al. Liver function of hepatitis B carriers in childhood. Pediatr Infect Dis J1993; 12:120-125.
29.
Castilla A. , Camps-Bansell J., Civeira MP, et al. Lymphoblastoid alpha interferon for chronic hepatitis C: a randomized controlled study. Am J Gastroenterol.1993;88:233-239.
30.
Alberti A., Morsica G., Chemello L.Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV . Lancet.1992;340:697-698.
31.
Gordon SC, Kodali V., Silverman AL, et al. Levels of hepatitis C virus RNA and liver histology in chronic type C hepatitis. Am J Gastroenterol.1994 ;89:1458-1461.
32.
Puoti M., Zonaro A., Ravaggi A., et al. Hepatitis C virus RNA and antibody response in the clinical course of acute hepatitis C virus infection. Hepatology.1992;16:877-881.
33.
Farci P., Alter HJ, Wong D., et al. A long term study of hepatitis C virus replication in non-A, non-B hepatitis. N Engl J Med.1991;325:98-104.
34.
Schvarcz R. , Glaumann H., Weiland O., et al. Interferon alpha- 2b treatment of chronic posttransfusion non-A, non-B/C hepatitis: long term outcome and effect of increased interferon dose in non-responders. Scand J Infect Dis. 1991;23:413-420.
35.
Lin R., Zimmerman M., Roach E., Farrell G.Alpha interferon 2b (IFN) in the treatment of chronic active hepatitis C: Interim report of the first multicenter Australian trial. Hepatology.1992; 16:75A. Abstract.
36.
Di Bisceglie AM, Martin P., Kassianides C., et al. Recombinant interferon alpha therapy for chronic hepatitis C. N Engl J Med.1989 ;321:506-510.
37.
Camps J., Crisostomo S., Garcia-Granero M., et al. Prediction of the response of chronic hepatitis C to interferon alpha: a statistical analysis of pretreatment variables. Gut.1993;34:1714-1717.
38.
Di Bisceglie AMInterferon therapy for chronic viral hepatitis . N Engl J Med.1994:330:137-138.
39.
Hagiwara H. , Hayashi N., Mita E., et al. Quantitative analysis of hepatitis C virus RNA in serum during interferon alpha therapy . Gastroenterology . 1993;104:877-883.
40.
Locasciulli A., Moncuzzi W., Tornotti G., et al. Hepatitis C virus infection and liver disease in children with thalassemia. Bone Marrow Transplant.1993; 12 (Suppl 1):18-20.
41.
Di Marco V. , Iacono Ol , Capra M.Alpha interferon treatment of chronic hepatitis C in young patients with homozygous β-thalassemia. Hematologia.1992; 77:502-506.
42.
Iino S., Hino K., Kuroki T., et al. Treatment of chronic hepatitis C with high dose interferon alpha 2-b. Dig Dis Sci.1993;38:612-618.
43.
Farci P., Mandas A., Coiana A. et al. Treatment of chronic hepatitis D with interferon alpha-2a. N Engl J Med.1994; 330:88-94.
44.
Craxi A., Di Marco V., Volpes R., et al. Treatment with recombinant alpha 2-b interferon of chronic HDV hepatitis in children. Prog Clin Biol Res. 1991;364:399-404.
45.
Renault PF, Hoofnagle JHSide effects of alpha interferon. Sem Liver Dis. 1989;9:273-277.
46.
Georgeston MJ, Yarze JC, Lalos AT, et al. Exacerbation of psoriasis due to interferon alpha treatment of chronic active hepatitis . Am J Gastroenterol.1993;88:1756-1758.
47.
Miller VS, Zweiner RJ, Fielman BAInterferon-associated refractory status epilepticus. Pediatrics . 1994;93:511-512.
48.
Ruiz-Moreno M., Rua MJ, Carreno V., et al. Autoimmune chronic hepatitis type 2 manifested during interferon therapy in children. J Hepatol . 1991;12:265-266.
49.
Berris B., Feinman SVThyroid dysfunction and liver injury following alpha interferon treatment of chronic viral hepatitis. Dig Dis Sci.199 1;36:1657-1660.
50.
Rossetti F. , Pontini F., Crivellaro C., et al. Interferon therapy of chronic delta hepatitis in patients cured of pediatric malignancies: possible harmful effect . Liver. 1991;11:255-259.
